Fabian Byvald | Karolinska Institutet

Publications
Public outreach and news

Articles

Article: DIABETOLOGIA. 2025;68(10):2277-2289
Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes
Parajuli A; Bendes A; Byvald F; Stone VM; Ringqvist EE; Butrym M; Angelis E; Kipper S; Bauer S; Roxhed N; Schwenk JM; Flodstrom-Tullberg M
Article: ANTIVIRAL RESEARCH. 2024;231:106021
Vemurafenib inhibits the replication of diabetogenic enteroviruses in intestinal epithelial and pancreatic beta cells
Butrym M; Byvald F; Blanter M; Ringqvist EE; Vasylovska S; Marjomaki V; Lau J; Stone VM; Flodstrom-Tullberg M
Article: ONCOIMMUNOLOGY. 2023;12(1):2209473
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma.
Rezapour A; Rydbeck D; Byvald F; Tasselius V; Danielsson G; Angenete E; Yrlid U
Article: CANCERS. 2022;14(12):2882
A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells.
Liang F; Nilsson LM; Byvald F; Rezapour A; Taflin H; Nilsson JA; Yrlid U

News from KI

Events from KI